CVS Health struck a deal with dissident Glenview Capital, giving the investor four board seats. Glenview had been pushing for changes at the health-care giant and had met with former CEO Karen Lynch prior to her ouster.

(Reuters) -CVS Health said on Monday it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund's chief executive Larry Robbins. Shares of the healthcare conglomerate rose nearly 3% in premarket trading.

CVS Health Corp. named Glenview Capital Management founder Larry Robbins to its board as part of an agreement with the activist firm that’s been pressuring the company for change.